REFERENCES
- Berman, J. D., Gallalee, J. F. & Gallalee, J. V. (1988). Pharmacokinetic of pentavalent antimony (Pentostam) in hamsters. American Journal of Tropical Medicine and Hygiene, 39, 41–45.
- Bruzual, E. & Arcay de Peraza, L. (1979). Contributión al estudio del efecto de los antimoniales pentavalentes y trivalentes en leishmaniasis cutanea experimental. Acta Cientifica Venezolana, 26, 8.
- Burguera, J. L., Burguera, M., Petit De Peña, Y., Añez, N. & Lugo De Yarbuh, A. (1993). Selective determination of antimony (III) and antimony (V) in serum and urine and total antimony in skin biopsies of patients with cutaneous leishmaniasis treated with meglumine antimoniate. Trace Elements in Medicine, 10, 66–70.
- Chulay, J. D., Fleckenstein, L. & Smith, D. H. (1988). Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 69–72.
- Croft, S. L., Neame, K. D. & Fiomewood, C. A. (1981). Accumulation of [125Sb]sodium stibogluconate in Leishmania mexicana amazonensis and L. donovani in vitro. Comparative Biochemistry and Physiology, 68, 95–98.
- Ferroni, P., Mazzotta, D., Mantovani, G., Guarneri, M., Fagioli, F., Balboni, P. G. & Paolini, I. (1987). Determination of antimony levels in organs of mice treated with an antimony-albumin complex by atomic absorbtion spectroscopy. Estratto dalla Revistas II Farmaco, 5, 123–129.
- Gagliardi, A. R. T., Veiga, J. P. R. & Marsden, P. D. (1984). Efeito do stibogluconato de sodio (Pentostam) sobre a area permeabilizante dos polipeptideos neuro-hipofisiarios in bexias de sapo isolada. In XX Congreso do Sociedade Brasileira de Medicina Tropical, Salvador, Bahia, pp. 80–81.
- Heath, S., Chance, M. L. & New, R. R. C. (1984). Quantitative and structural studies and the uptake of drug loade liposomes by mononuclear phagocytes infected with Leishmania donovani. Molecular and Biochemical Parasitology, 12, 49–60.
- Kellum, R. E. & Riyadh, F. A. C. P. (1985). Treatment of cutaneous leishmaniasis with intralesional drug (Pentostam). Journal of the American Academy of Dermatology, 15, 620–622.
- Marsden, P. D. & Jones, T. C. (1985). Clinical manifestations, diagnosis and treatment of leishmaniasis. In Leishmaniasis, eds. Chang, K. F. & Bray, R. S., pp. 183–198. Amsterdam: Elsevier Science Publisher.
- Petit de Peña, Y., Gallignani, M., Burguera, M., Burguera, J. L., Añez, N. & Lugo, A. (1990). Selective determination of antimony (III) and antimony (V) in blood serum and urine by hydride generation and atomic absorption spectrometry. Journal of the Brazilian Chemical Society, 1, 72–75.
- Rees, P. H., Keating, M. I., Kager, P. A. & Hockmeyer, W. T. (1980). Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet, ii, 226–229.
- Sharquie, K. E., Al-Talib, K. R., Chu, A. C. (1988). Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. British Journal of Dermatology, 119, 53–57.
- Veiga, J. P. R., Sosa, T. T., Kimachi, T., Wolff, E. R., Sampaio, P. N., Gagliardi, A. R. T., Junqueira, J. R., Costa, L. F. & Marsden, P. D. (1985). Funcao renal em pacientes con leishmaniasis mucocutanea tratados con antimoniais pentavalentes. Revista do Instituto de Medicina Tropical Sao Paulo, 21, 298–302.